The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / October / Raman Spectroscopy Distinguishes SARS-CoV-2 Variants
Spectroscopy News and Research

Raman Spectroscopy Distinguishes SARS-CoV-2 Variants

Researchers propose Raman analysis as a complement to sequencing for studying SARS-CoV-2 RNA

10/28/2026 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Raman spectroscopy combined with spectral barcoding distinguished RNA from 20 SARS-CoV-2 variants and subvariants in a laboratory study, suggesting a possible complementary method for studying viral RNA structure.

The research, published in Advanced Science, examined RNA extracted from the original Japanese isolate, the Alpha, Beta, Gamma, Delta, Lambda, Theta, and Mu variants, and 12 Omicron subvariants. Giuseppe Pezzotti of Kansai Medical University and colleagues described the resulting structural fingerprints as a “Raman genome.”

The researchers propagated each viral strain in cell culture before extracting RNA from the culture supernatant. Spectra were collected with a confocal Raman spectrometer using a 532-nm laser. For each RNA sample, the team collected 10 spectra from different locations across an area of approximately 2 mm² and averaged the results.

Measurements covered the Raman shift range from 400 to 1,800 cm⁻¹. The spectra contained signals associated with the phosphodiester backbone, ribofuranose rings, and the RNA bases adenine, cytosine, guanine, and uracil.

Although the overall spectra were similar, the researchers identified differences in signals linked to RNA backbone conformation, phosphate bonds, base pairing, and secondary structure. They used computational deconvolution to separate overlapping spectral bands and convert selected features into barcodes.

Conventional principal component analysis provided limited discrimination and could distinguish only some of the strains. In contrast, the Raman barcodes differed across all 20 samples. The team linked some of these differences to predicted secondary structures generated from nucleotide sequences using RNAfold software.

Signals at approximately 432 and 1,460 cm⁻¹ were associated with structural characteristics including the number of hairpin loops and stem length. These relationships indicate that Raman spectroscopy reflects changes in RNA folding and molecular organization rather than simply measuring the relative abundance of individual bases.

The method does not sequence RNA or identify individual nucleotide substitutions. Instead, it detects the structural effects of sequence variation, including changes in base pairing, stacking, backbone geometry, and hydrogen bonding. The authors therefore presented Raman analysis as a potential complement to next-generation sequencing rather than a replacement.

The study was a proof of concept involving a finite set of purified RNA samples from cell-culture supernatants. Its ability to recognize previously unseen variants or strains separated by only a few mutations remains unknown. Testing is also needed with clinical specimens, which may contain host nucleic acids, proteins, mucus, cellular debris, and variable concentrations of viral RNA.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #3
Spectroscopy
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

More Bang for Your Buck
Spectroscopy
More Bang for Your Buck

December 4, 2024

1 min read

Researchers develop more stable catalysts for dry reforming of methane – a promising method for carbon capture and utilization (CCU)

The Analytical Scientist Innovation Awards 2024: #1
Spectroscopy
The Analytical Scientist Innovation Awards 2024: #1

December 10, 2024

2 min read

And the technology ranked first in our 2024 Innovation Awards is…

The Analytical Scientist Innovation Awards 2024
Spectroscopy
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.